Financials
- Market Capitalization 21.01 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4584 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.44 USD | -0.22% | +2.60% | -1.90% | +129.74% | 21.76 M USD | ||
| 4592 | SKYE Skye Bioscience, Inc. - Common Stock | 0.61 USD | -1.61% | -14.08% | -16.44% | -23.75% | 21.44 M USD | ||
| 4603 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.61 USD | -0.76% | -6.79% | +6.10% | -16.88% | 20.86 M USD | ||
| 4614 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 4.78 USD | -4.78% | -17.01% | -49.95% | +288.62% | 20.02 M USD |